KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Receivables (2016 - 2026)

Pfizer has reported Receivables over the past 18 years, most recently at $12.6 billion for Q1 2026.

  • Quarterly Receivables rose 6.25% to $12.6 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $12.6 billion through Mar 2026, up 6.25% year-over-year, with the annual reading at $11.9 billion for FY2025, 3.59% up from the prior year.
  • Receivables was $12.6 billion for Q1 2026 at Pfizer, up from $11.9 billion in the prior quarter.
  • Over five years, Receivables peaked at $16.2 billion in Q4 2022 and troughed at $10.2 billion in Q3 2023.
  • The 5-year median for Receivables is $11.9 billion (2025), against an average of $12.5 billion.
  • Year-over-year, Receivables surged 39.98% in 2022 and then plummeted 33.68% in 2023.
  • A 5-year view of Receivables shows it stood at $11.0 billion in 2022, then grew by 5.61% to $11.6 billion in 2023, then fell by 0.89% to $11.5 billion in 2024, then grew by 3.59% to $11.9 billion in 2025, then grew by 5.99% to $12.6 billion in 2026.
  • Per Business Quant, the three most recent readings for PFE's Receivables are $12.6 billion (Q1 2026), $11.9 billion (Q4 2025), and $14.3 billion (Q3 2025).